To gain insight into regulatory mechanisms that protect against the onset of cognitive decline and AD, we characterized the cellular response to early stages of Aβ deposition and abnormal tau accumulation in aging humans and AD mouse models. The gene discussed is MAPT; the disease is Alzheimer disease.